Understanding how cells control gene messages in conditions like Fragile X Syndrome
Nonsense-mediated mRNA decay and beyond
This research explores how our cells fix mistakes in genetic messages, which could help us understand conditions like Fragile X Syndrome and how our immune system works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11134665 on NIH RePORTER |
What this research studies
Our bodies have a natural way to clean up faulty genetic instructions, called nonsense-mediated mRNA decay (NMD). This process is crucial because errors in genetic messages can lead to various health conditions. We are particularly interested in how NMD is affected in Fragile X Syndrome, a common genetic cause of intellectual disability and autism, and how it influences our immune system. By understanding these cellular mechanisms, we hope to uncover new ways to approach these conditions. We are studying how specific proteins interact to protect genetic messages and prevent an overactive immune response.
Who could benefit from this research
Good fit: This foundational research does not involve direct patient participation at this stage, but future studies building on this work may seek individuals with Fragile X Syndrome or certain immune conditions.
Not a fit: Patients not affected by genetic disorders related to mRNA decay or specific immune dysfunctions are unlikely to directly benefit from this particular basic science research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of Fragile X Syndrome and immune disorders, potentially opening doors for new treatments.
How similar studies have performed: This research builds upon decades of work on nonsense-mediated mRNA decay, with prior findings already used by clinicians, but its specific focus on Fragile X Syndrome and immune regulation represents a novel extension.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Maquat, Lynne E — University of Rochester
- Study coordinator: Maquat, Lynne E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.